APA (7th ed.) Citation

A, S., N, S., Y, O., D, I., A, S., M, Y., . . . Y, U. (2024). Immunoglobulin G4-related Dacryoadenitis Successfully Treated with Baricitinib. Internal medicine (Tokyo, Japan), 63(3), 461. https://doi.org/10.2169/internalmedicine.1862-23

Chicago Style (17th ed.) Citation

A, Suenaga, et al. "Immunoglobulin G4-related Dacryoadenitis Successfully Treated with Baricitinib." Internal Medicine (Tokyo, Japan) 63, no. 3 (2024): 461. https://doi.org/10.2169/internalmedicine.1862-23.

MLA (9th ed.) Citation

A, Suenaga, et al. "Immunoglobulin G4-related Dacryoadenitis Successfully Treated with Baricitinib." Internal Medicine (Tokyo, Japan), vol. 63, no. 3, 2024, p. 461, https://doi.org/10.2169/internalmedicine.1862-23.